Hanmi Financial Corp. (NASDAQ: HAFC) was started with a Neutral rating and $9 target price (versus an $8.38 close) at Wedbush. The company was noted as having the highest COVID-19-impacted loan portfolio of its peers.
Iovance Biotherapeutics Inc. (NASDAQ: IOVA) closed up 1.8% at $32.06 on Monday and was indicated down 20% at $25.45 on Tuesday after FDA questions about its melanoma drug. H.C. Wainwright maintained its Buy rating but cut its price target to $46 from $47.
Las Vegas Sands Corp. (NYSE: LVS) was named as the Zacks Bear of the Day stock. The firm said that while most gambling stocks are on a heater, investors in this stock continue to be on tilt. Shares last closed at $46.22 and have a consensus price target of $59.06.
Lightspeed POS Inc. (NYSE: LSPD) was started with an Overweight rating and a $40 target price at Barclays. Shares closed up 2.3% at $32.32 ahead of the call, and the Barclays price target is a new street-high among sell-side analysts.
Marvell Technology Group Ltd. (NASDAQ: MRVL) was reiterated as Buy and its price target was raised to $47 from $38 (versus a $41.52 close) at Rosenblatt. The stock closed up 4.4% on Monday and has a $42.29 consensus price target.
Miragen Therapeutics Inc. (NASDAQ: MGEN) was downgraded to Neutral from Buy at H.C. Wainwright. Its shares closed at $0.76 on Monday and were down more than 26% at $0.56 on Tuesday, after discontinuing a cutaneous T-cell lymphoma study.
MyoKardia Inc. (NASDAQ: MYOK) was up 57% at $220.34 on Monday after news that it was being acquired by Bristol-Myers Squibb. Now the analysts are walking away from their ratings, with merger-related downgrades from BMO Capital Markets, Citigroup, JPMorgan, Morgan Stanley, Wells Fargo and others.
Northrup Grumman Corp. (NYSE: NOC) was raised to Outperform from Sector Perform with a $391 price target (versus a $312.18 close) at RBC Capital Markets.
Proofpoint Inc. (NASDAQ: PFPT) was reiterated as Outperform with a $135 target price (versus a $103.62 close) at Wedbush. The firm sees higher Microsoft Office 365 adoption continues to lead to more migrations to Proofpoint.
Qiagen N.V. (NYSE: QGEN) was raised to Buy from Neutral with a $59 price objective at BofA Securities. Shares closed up 1.7% at $53.20 on Monday and have a $52.64 consensus price target.
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) was reiterated as Outperform and its price target was raised to $650 from $630 at SVB Leerink. The stock closed up 7.1% at $605.08 on Monday, after it was used as one of President Trump’s COVID-19 treatments.
Shopify Inc. (NYSE: SHOP) was reiterated as Overweight and its target price was raised to $1,250 from $1,150 (versus a $1,065.53 close) at KeyBanc Capital Markets. The consensus price target was $1,113.25 ahead of the call.
Tradeweb Markets Inc. (NASDAQ: TW) was reiterated as Buy and its price target was raised to $62 from $60 (versus a $57.56 close) at Rosenblatt.
Raymond James restarted coverage on the top cybersecurity software stocks, and three companies look in particular good to the analysts, especially with demand from major corporations remaining very robust.
Monday’s top analyst upgrades and downgrades included American Express, AT&T, CRISPR Therapeutics, DocuSign, ONEOK, Regeneron Pharmaceuticals, Shopify and Tesla.